Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zymeworks Q3 EPS $(0.26) Beats $(0.35) Estimate, Sales $27.614M Miss $29.460M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:19pm
Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.35) by 24.86 percent. This is a 33.33 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $27.614 million which missed the analyst consensus estimate of $29.460 million by 6.27 percent. This is a 72.59 percent increase over sales of $16.000 million the same period last year.

Posted In: ZYME


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist